The differential diagnosis and bone marrow evaluation of new-onset pancytopenia

American Journal of Clinical Pathology

Volumn 139, Issue 1, 2013, Pages 9-29

  Weinzierl, Elizabeth P ^a   Arber, Daniel A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow findings; New onset cytopenias; Pancytopenia

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIPROTOZOAL AGENT; ANTITHYROID AGENT; BENZENE; CARBIMAZOLE; CARBONATE DEHYDRATASE INHIBITOR; CHLORAMPHENICOL; CHLORDIAZEPOXIDE; CORTICOSTEROID; CYTOTOXIC AGENT; ESTROGEN DERIVATIVE; IBUPROFEN; INDOMETACIN; MEPROBAMATE; METHYLDOPA; METHYPRYLON; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYLBUTAZONE; PIPERACETAZINE; POTASSIUM PERCHLORATE; PROCHLORPERAZINE; QUINIDINE; SEDATIVE AGENT; SULINDAC; UNINDEXED DRUG;

APLASTIC ANEMIA; AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; BONE MARROW EXAMINATION; CHRONIC LEUKEMIA; CLINICAL EVALUATION; CONSULTATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FANCONI ANEMIA; FIBROSIS; HEMATOPOIESIS; HUMAN; INFECTION; LEUKEMIA; NONHODGKIN LYMPHOMA; NUTRITIONAL DEFICIENCY; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ADULT; AUTOIMMUNE DISEASES; BONE MARROW CELLS; BONE MARROW DISEASES; BONE MARROW EXAMINATION; CHILD; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; INFANT; MALE; MIDDLE AGED; PANCYTOPENIA; REFERRAL AND CONSULTATION;

EID: 84871723686     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP50AEEYGREWUZ     Document Type: Review

References (123)

1. Fanconi G. Familiare infantile perniziosaartige anamie (pernizioses blutbild und konstitution). Z Kinderheilkunde. 1927;117.
2. Giampietro PF, Adler-Brecher B, Verlander PC, et al. The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics. 1993;91:1116-1120. (Pubitemid 23165787)
3. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110. (Pubitemid 26377695)
4. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256. (Pubitemid 36182492)
5. Butturini A, Gale RP, Verlander PC, et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry Study. Blood. 1994;84:1650-1655. (Pubitemid 24273037)
6. Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res. 1973;33:1829-1836.
7. Auerbach AD, Wolman SR. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature. 1976;261:494-496.
8. Zinsser F. Atrophia cutis reticularis cum pigtnentatione, dystrophia unguim et leukuplakia oris. Ikonographia Dermatol (Hyoto). 1910;5:219-223.
9. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768-779.
10. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551-555.
11. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432-435. (Pubitemid 32928599)
12. Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97-101. (Pubitemid 36068690)
13. Woloszynek JR, Rothbaum RJ, Rawls AS, et al. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood. 2004;104:3588-3590. (Pubitemid 39564431)
14. Smith OP, Hann IM, Chessells JM, et al. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol. 1996;94:279-284. (Pubitemid 26247985)
15. Ballmaier M, Germeshausen M, Schulze H, et al. c-Mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001;97:139-146. (Pubitemid 32061253)
16. Ihara K, Ishii E, Eguchi M, et al. Identification of mutations in the c-Mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A. 1999;96:3132-3136. (Pubitemid 29148856)
17. King S, Germeshausen M, Strauss G, et al. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol. 2005;131:636-644. (Pubitemid 43899631)
18. Mukai HY, Kojima H, Todokoro K, et al. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thromb Haemost. 1996;76:675-678. (Pubitemid 26388167)
19. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95-109. (Pubitemid 46025500)
20. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27:519-525.
21. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959. (Pubitemid 129515904)
22. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461-473. (Pubitemid 37456808)
23. zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827-834. (Pubitemid 40403278)
24. McClain K, Gehrz R, Grierson H, et al. Virus-associated histiocytic proliferations in children. frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol. 1988;10:196-205.
25. Ost A, Nilsson-Ardnor S, Henter JI. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology. 1998;32:310-316. (Pubitemid 28186588)
26. Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;51:402-404.
27. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509-2519.
28. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63-70.
29. Brunning RD, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms: overview. In: Swerdlow S, Campo E, Harris NL, et al, eds. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
30. Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/ myeloproliferative diseases. Pathobiology. 2007;74:97-114. (Pubitemid 46985282)
31. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711. (Pubitemid 23159009)
32. Mukhina GL, Buckley JT, Barber JP, et al. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol. 2001;115:476-482. (Pubitemid 34203519)
33. Kawaguchi T, Nakakuma H. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2007;86:27-32. (Pubitemid 47204486)
34. Li Y, Li X, Ge M, et al. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience. Ann Hematol. 2011;90:529-537.
35. Wallerstein RO, Condit PK, Kasper CK, et al. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA. 1969;208:2045-2050.
36. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534-546. (Pubitemid 34252288)
37. Shimamura A, Guinan E. Acquired and inherited aplastic anemia syndromes. In: Greer J, Foerster J, Lukens J, et al, eds. Wintrobe's Clinical Hematology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
38. Greenburg L Mayers MR, Goldwater L, et al. Benzene (Benzol) poisoning in the rotogravure printing industry in New York City. J Ind Hyg Toxicol. 1939;21:395-420.
39. Vigliani EC, Saita G. Benzene and leukemia. N Engl J Med. 1964;271:872-876.
40. Sanchez Medal L, Castanedo JP, Garcia Rojas F. Insecticides and aplastic anemia. N Engl J Med. 1963;269:1365-1367.
41. Loge JP. Aplastic anemia following exposure to benzene hexachloride (lindane). JAMA. 1965;193:110-114.
42. Powars D. Aplastic anemia secondary to glue sniffing. N Engl J Med. 1965;273:700-702.
43. Weisdorf D, Chao N, Waselenko JK, et al. Acute radiation injury: contingency planning for triage, supportive care, and transplantation. Biol Blood Marrow Transplant. 2006;12:672-682.
44. Arian-Schad KS, Kapp DS, Hackl A, et al. Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report. Gynecol Oncol. 1990;39:47-55. (Pubitemid 20378258)
45. Miron D, Luder A, Horovitz Y, et al. Acute human parvovirus B-19 infection in hospitalized children: a serologic and molecular survey. Pediatr Infect Dis J. 2006;25:898-901. (Pubitemid 44510583)
46. Mishra B, Malhotra P, Ratho RK, et al. Human parvovirus B19 in patients with aplastic anemia. Am J Hematol. 2005;79:166-167. (Pubitemid 40770678)
47. Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells. 1996;14:151-163. (Pubitemid 26109197)
48. Bain BJ. The haematological features of HIV infection. Br J Haematol. 1997;99:1-8. (Pubitemid 27461320)
49. Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol. 1987;66:251-256. (Pubitemid 17087425)
50. Hagler L, Pastore RA, Bergin JJ, et al. Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. Medicine (Baltimore). 1975;54:139-164.
51. Locasciulli A, Bacigalupo A, Bruno B, et al. Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe: a report of the EBMT Aplastic Anaemia Working Party. Br J Haematol. 2010;149:890-895.
52. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis: non-A, non-B, non-C? JAMA. 1992;267:2051-2054.
53. Pol S, Driss F, Devergie A, et al. Is hepatitis C virus involved in hepatitis-associated aplastic anemia? Ann Intern Med. 1990;113:435-437. (Pubitemid 20333451)
54. Brown KE, Tisdale J, Barrett AJ, et al. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336:1059-1064. (Pubitemid 27163858)
55. Stefos A, Georgiadou SP, Gioti C, et al. Leptospirosis and pancytopenia: two case reports and review of the literature. J Infect. 2005;51:e277-e280. (Pubitemid 43008977)
56. Rosenfeld SJ, Young NS. Viruses and bone marrow failure. Blood Rev. 1991;5:71-77.
57. Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21:245-253. (Pubitemid 47212601)
58. Ehrlich P. Ueber einen fall von anamie mit bemerkungen uber regenerative veranderungen des knochenmarks. Charitee-Annalen. 1888;13:300-309.
59. Stibbe KJ, Wildschut HI, Lugtenburg PJ. Management of aplastic anemia in a woman during pregnancy: a case report. J Med Case Rep. 2011;5:66.
60. van Besien K, Tricot G, Golichowski A, et al. Pregnancy-associated aplastic anemia: report of 3 cases. Eur J Haematol. 1991;47:253-256.
61. Knispel JW, Lynch VA, Viele BD. Aplastic anemia in pregnancy: a case report, review of the literature, and a re-evaluation of management. Obstet Gynecol Surv. 1976;31:523-538.
62. Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993;7:199-207. (Pubitemid 24004827)
63. Nesher G, Hanna VE, Moore TL, et al. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum. 1994;24:165-172.
64. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med. 1991;80:605-612.
65. Voulgarelis M, Giannouli S, Tasidou A, et al. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol. 2006;81:590-597. (Pubitemid 44066169)
66. Pereira RM, Velloso ER, Menezes Y, et al. Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias. Clin Rheumatol. 1998;17:219-222. (Pubitemid 28346372)
67. Feng CS, Ng MH, Szeto RS, et al. Bone marrow findings in lupus patients with pancytopenia. Pathology. 1991;23:5-7.
68. Deane S, Selmi C, Teuber SS, et al. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010;153:109-120.
69. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561-566.
70. Zeigler Z, Shadduck RK, Winkelstein A, et al. Immune hemolytic anemia and thrombocytopenia secondary to quinidine: in vitro studies of the quinidine-dependent red cell and platelet antibodies. Blood. 1979;53:396-402. (Pubitemid 9140396)
71. Murphy MF, Riordan T, Minchinton RM, et al. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. Br J Haematol. 1983;55:155-160. (Pubitemid 13041088)
72. Maguire RB, Stroncek DF, Campbell AC. Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies. Ann Intern Med. 1993;119:215-217. (Pubitemid 23327621)
73. Stroncek DF. Drug-induced immune neutropenia. Transfus Med Rev. 1993;7:268-274. (Pubitemid 23297290)
74. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest. 1966;45:645-657.
75. Casserd F, Finch CA, Giblett ER, et al. Studies on the pathogenesis of splenic anemia. Blood. 1956;11:1118-1131.
76. Jandl JH, Aster RH. Increased splenic pooling and the pathogenesis of hypersplenism. Am J Med Sci. 1967;253:383-398.
77. Hess CE. Approach to patients with lymphadenopathy and splenomegaly. In: Thorup O Jr, ed. Fundamentals in Clinical Hematology. 5th ed. Philadelphia, PA: WB Saunders; 1987.
78. Carr JA, Shurafa M, Velanovich V. Surgical indications in idiopathic splenomegaly. Arch Surg. 2002;137:64-68. (Pubitemid 34041822)
79. Ruocco L, Baldi A, Cecconi N, et al. Severe pancytopenia due to copper deficiency: case report. Acta Haematol. 1986;76:224-226. (Pubitemid 17057974)
80. Wasa M, Satani M, Tanano H, et al. Copper deficiency with pancytopenia during total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1994;18:190-192. (Pubitemid 24102245)
81. Imataki O, Ohnishi H, Kitanaka A, et al. Pancytopenia complicated with peripheral neuropathy due to copper deficiency: clinical diagnostic review. Intern Med. 2008;47:2063-2065.
82. Ito Y, Ando T, Nabeshima T. Latent copper deficiency in patients receiving low-copper enteral nutrition for a prolonged period. JPEN J Parenter Enteral Nutr. 2005;29:360-366. (Pubitemid 44296704)
83. Halfdanarson TR, Kumar N, Li CY, et al. Hematological manifestations of copper deficiency: a retrospective review. Eur J Haematol. 2008;80:523-531. (Pubitemid 351677455)
84. Gyorffy EJ, Chan H. Copper deficiency and microcytic anemia resulting from prolonged ingestion of over-the-counter zinc. Am J Gastroenterol. 1992;87:1054-1055.
85. Fiske DN, McCoy HE III, Kitchens CS. Zinc-induced sideroblastic anemia: report of a case, review of the literature, and description of the hematologic syndrome. Am J Hematol. 1994;46:147-150. (Pubitemid 24181629)
86. Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002;100:1493-1495. (Pubitemid 34864311)
87. Huff JD, Keung YK, Thakuri M, et al. Copper deficiency causes reversible myelodysplasia. Am J Hematol. 2007;82:625-630. (Pubitemid 47015285)
88. Van de Velde A, Van Droogenbroeck J, Tjalma W, et al. Folate and vitamin B(12) deficiency presenting as pancytopenia in pregnancy: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2002;100:251-254. (Pubitemid 34028152)
89. Sarode R, Garewal G, Marwaha N, et al. Pancytopenia in nutritional megaloblastic anaemia: a study from north-west India. Trop Geogr Med. 1989;41:331-336. (Pubitemid 20286944)
90. Khunger JM, Arulselvi S, Sharma U, et al. Pancytopenia: a clinico haematological study of 200 cases. Indian J Pathol Microbiol. 2002;45:375-379.
91. Kumar R, Kalra SP, Kumar H, et al. Pancytopenia: a six year study. J Assoc Physicians India. 2001;49:1078-1081.
92. Abella E, Feliu E, Granada I, et al. Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am J Clin Pathol. 2002;118:582-588. (Pubitemid 44698515)
93. Redaelli A, Laskin BL, Stephens JM, et al. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005;14:53-62. (Pubitemid 40314386)
94. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19:379-390.
95. Foucar K, Langdon RM II, Armitage JO, et al. Myelodysplastic syndromes: a clinical and pathologic analysis of 109 cases. Cancer. 1985;56:553-561. (Pubitemid 15035583)
96. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37:15-29. (Pubitemid 30080244)
97. Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13:609-630.
98. Frassoldati A, Lamparelli T, Federico M, et al. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL) - Italian Cooperative Group for Hairy Cell Leukemia. Leuk Lymphoma. 1994;13:307-316. (Pubitemid 24141338)
99. Flandrin G, Sigaux F, Sebahoun G, et al. Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin Oncol. 1984;11:458-471. (Pubitemid 15150319)
100. Go RS, Lust JA, Phyliky RL. Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia. Semin Hematol. 2003;40:196-200. (Pubitemid 36842597)
101. Morice WG, Kurtin PJ, Tefferi A, et al. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood. 2002;99:268-274.
102. Go RS, Tefferi A, Li CY, et al. Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia. Blood. 2000;96:3644-3446.
103. Ohgami RS, Ohgami JK, Pereira IT, et al. Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies. Leukemia. 2011;25:1439-1443.
104. Blade J, Rosinol L. Complications of multiple myeloma. Hematol Oncol Clin North Am. 2007;21:1231-1246. (Pubitemid 350051348)
105. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21-33. (Pubitemid 36033957)
106. Blade J, San Miguel JF, Fontanillas M, et al. Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients. Hematol J. 2001;2:272-278. (Pubitemid 32771602)
107. Thiele J, Kvasnicka HM. Myelofibrosis in chronic myeloproliferative disorders: dynamics and clinical impact. Histol Histopathol. 2006;21:1367-1378. (Pubitemid 44614518)
108. Kreft A, Buche G, Ghalibafian M, et al. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies. Acta Haematol. 2005;113:137-143. (Pubitemid 40522818)
109. Hasselbalch HC. Idiopathic myelofibrosis: an update with particular reference to clinical aspects and prognosis. Int J Clin Lab Res. 1993;23:124-138.
110. Buhr T, Busche G, Choritz H, et al. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol. 2003;119:152-158. (Pubitemid 37047910)
111. Myers CE, Chabner BA, De Vita VT, et al. Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapy. Blood. 1974;44:197-204.
112. Meadows LM, Rosse WR, Moore JO, et al. Hodgkin's disease presenting as myelofibrosis. Cancer. 1989;64:1720-1726. (Pubitemid 19251146)
113. Sobrinho-Simoes M, Paiva ME, Goncalves V, et al. Hodgkin's disease with predominant infradiaphragmatic involvement and massive invasion of the bone marrow. a necropsic study of nine cases. Cancer. 1983;52:1927-1932. (Pubitemid 14228163)
114. Neiman RS, Rosen PJ, Lukes RJ. Lymphocyte-depletion Hodgkin's disease: a clinicopathological entity. N Engl J Med. 1973;288:751-755.
115. Makoni SN, Laber DA. Clinical spectrum of myelophthisis in cancer patients. Am J Hematol. 2004;76:92-93. (Pubitemid 38579549)
116. Brochamer WL Jr, Keeling MM. The bone marrow biopsy, osteoscan, and peripheral blood in non-hematopoietic cancer. Cancer. 1977;40:836-840. (Pubitemid 8177907)
117. Krishnan C, George TI, Arber DA. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas. Appl Immunohistochem Mol Morphol. 2007;15:1-7. (Pubitemid 46673310)
118. Rizzi R, Pastore D, Liso A, et al. Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma. 2004;45:561-566. (Pubitemid 38196040)
119. Bass RD, Pullarkat V, Feinstein DI, et al. Pathology of autoimmune myelofibrosis: a report of three cases and a review of the literature. Am J Clin Pathol. 2001;116:211-216. (Pubitemid 33044325)
120. Mert A, Bilir M, Tabak F, et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology. 2001;6:217-224. (Pubitemid 32896552)
121. Avasthi R, Mohanty D, Chaudhary SC, et al. Disseminated tuberculosis: interesting hematological observations. J Assoc Physicians India. 2010;58:243-244.
122. Stephan JL, Galambrun C, Dutour A, et al. Myelofibrosis: an unusual presentation of vitamin D-deficient rickets. Eur J Pediatr. 1999;158:828-829. (Pubitemid 29448476)
123. Weinberg SG, Lubin A, Wiener SN, et al. Myelofibrosis and renal osteodystrophy. Am J Med. 1977;63:755-764. (Pubitemid 8222942)